Telangana carries out sight-saving treatment on 143 newborns 

Telangana recorded the highest numbers of screening and treatments for Retinotherapy of Prematurity (ROP), an eye disease that affects prematurely born babies.

Published: 12th June 2019 07:48 AM  |   Last Updated: 12th June 2019 01:02 PM   |  A+A-


For representational purposes (File Photo| AP)

By Express News Service

HYDERABAD: To tackle Retinotherapy of Prematurity (ROP), the Public Health Foundation of India, Union Health Ministry, Diamond Jubilee Trust and the London School of Hygiene and Tropical Medicine, implemented the ROP in 22 special new-born care units across district hospitals, and medical colleges in four states - Telangana, Maharashtra, Madhya Pradesh and Odisha. 

Out of the 317 babies that received sight-saving treatment in these states, Telangana alone contributed to 143 cases of successful treatment, making it the State with one of the highest numbers of screening and treatments. 

Dr Ranjan Shukla, principal co-investigator of DRROP (Diabetic Retinopathy and Retinopathy of Prematurity), said  “In over 90 per cent of the cases ROP regresses on its own. Only 10 per cent of the cases advances into retinal detachment and damage.

However,  it is not possible to know which 10 per cent will advance into something adverse and therefore the screening of the whole lot was carried on until the retinal vessels mature till the nasal side.

In almost 60 per cent of the babies, the first screening itself showed that the vessel has matured sufficiently. However, for the rest 40%, a follow up of 3-4 screening sessions for two to four weeks is required.” 

Professor GVS Murthy, the principal investigator of the DRROP, said “Private practitioners  do not want to touch at it is extremely sensitive and requires skill to not only screen but also administer the treatment required.” 

Stay up to date on all the latest Telangana news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp